Centerpoint Advisors’s LeMaitre Vascular LMAT Stock Holding History

Centerpoint Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22K	Sell	226 -2	-0.9%	-$205	0.01%	249
2026 Q1	$25K	Hold	228	–	–	0.01%	207
2025 Q4	$18K	Hold	228	–	–	0.01%	272
2025 Q3	$20K	Sell	228 -1	-0.4%	-$89	0.01%	254
2025 Q2	$19K	Hold	229	–	–	0.01%	252
2025 Q1	$19K	Sell	229 -17,526	-99%	-$1.63M	0.01%	249
2024 Q4	$1.64M	Hold	17,755	–	–	0.57%	22
2024 Q3	$1.65M	Hold	17,755	–	–	0.57%	22
2024 Q2	$1.46M	Sell	17,755 -38	-0.2%	-$2.79K	0.53%	25
2024 Q1	$1.18M	Hold	17,793	–	–	0.44%	29
2023 Q4	$1.01M	Hold	17,793	–	–	0.4%	31
2023 Q3	$969K	Sell	17,793 -4	-0%	-$237	0.41%	32
2023 Q2	$1.2M	Hold	17,797	–	–	0.49%	28
2023 Q1	$916K	Buy	17,797 +17,484	+5,586%	+$849K	0.4%	32
2022 Q4	$14K	Buy	+313	New	+$14.7K	0.01%	264

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Centerpoint Advisors's LMAT Position: Q2 2026 in Review

Centerpoint Advisors reduced its LeMaitre Vascular (LMAT) stake by 0.88% in Q2 2026, selling an estimated $205 and leaving 226 shares worth $22K. The position accounts for 0.01% of the portfolio, ranked #249.

Centerpoint Advisors first reported a position in LMAT in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.65M in Q3 2024. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Centerpoint Advisors held 226 shares of LeMaitre Vascular worth $22K as of Q2 2026.
Centerpoint Advisors sold 2 LeMaitre Vascular shares in Q2 2026, an estimated $205.
LeMaitre Vascular made up 0.01% of Centerpoint Advisors's portfolio in Q2 2026, its #249 holding.
Centerpoint Advisors first reported a position in LeMaitre Vascular in Q4 2022 and has held it in 15 quarters since.
Centerpoint Advisors's LeMaitre Vascular position peaked at $1.65M in Q3 2024.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Centerpoint Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.